BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11695236)

  • 1. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
    Paulsen JE; Elgjo K
    In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo growth inhibition of human colon carcinoma cells (HT-29) by all-trans-retinoic acid, difluoromethylornithine, and colon mitosis inhibitor, individually and in combination.
    Paulsen JE; Lützow-Holm C
    Anticancer Res; 2000; 20(5B):3485-9. PubMed ID: 11131651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of tripeptide colon mitosis inhibitor to suppress the cell proliferation of dimethylhydrazine-induced colonic cancers in rats.
    Pawlikowski M; Zerek-Mełeń G; Stepień H; Lachowicz A; Winczyk K; Szadowska A
    Cytobios; 1993; 76(306-307):151-5. PubMed ID: 8181305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines.
    Sandgren S; Belting M
    Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition by polyamine biosynthesis inhibitor DFMO of the growth of transplanted human colon cancer in nude mice].
    Wang M
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):335-7. PubMed ID: 1782843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthetic colon peptide pyroGlu-His-GlyOH inhibits growth of human colon carcinoma cells (HT-29) transplanted subcutaneously into athymic mice.
    Paulsen JE
    Carcinogenesis; 1993 Aug; 14(8):1719-21. PubMed ID: 8353859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth.
    Hess C; Vuong V; Hegyi I; Riesterer O; Wood J; Fabbro D; Glanzmann C; Bodis S; Pruschy M
    Br J Cancer; 2001 Dec; 85(12):2010-6. PubMed ID: 11747347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human HT-29 colon carcinoma cells: mucin production and tumorigenicity in relation to growth phases.
    Niv Y; Schwartz B; Amsalem Y; Lamprecht SA
    Anticancer Res; 1995; 15(5B):2023-7. PubMed ID: 8572596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin].
    Zhang GF; Wang YH; Zhang MA; Wang Q; Luo YB; Wang DS; Han CR
    Ai Zheng; 2002 Jan; 21(1):50-3. PubMed ID: 12500397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growth.
    Burg C; Patry Y; Le Pendu J; Moreau M; Tesson L; Godard A; Soulillou JP; Meflah K; Anegon I
    Cytokine; 1995 Nov; 7(8):784-92. PubMed ID: 8664445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early oncogene mRNA expression in HT-29 cells treated with the endogenous colon mitosis inhibitor pyroglutamyl-histidyl-glycine.
    Reichelt WH; Liu Y; Luna L; Eigjo K; Reichelt KL
    Anticancer Res; 2002; 22(2A):991-6. PubMed ID: 12014683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
    Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
    Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
    Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126.
    Cullis ER; Kalber TL; Ashton SE; Cartwright JE; Griffiths JR; Ryan AJ; Robinson SP
    Microvasc Res; 2006 Mar; 71(2):76-84. PubMed ID: 16530791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.